InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

Current share price for MVP : $0.445 0.005 (1.11%)+

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$50 Date of AGM and Closing Date for Director Nominations 18 Sep 2026 9:00AM $0.485 $0.445 fallen by 8.25%
$50 MVP Announces FY26 Full Year Results 20 Aug 2026 8:56AM $0.515 $0.445 fallen by 13.59%
$50 FY26 Full year Results Investor Presentation 20 Aug 2026 8:56AM $0.515 $0.445 fallen by 13.59%
$50 FY26 Full Year Results 20 Aug 2026 8:55AM $0.515 $0.445 fallen by 13.59%
$50 Change in substantial holding 17 Aug 2026 4:53PM $0.460 $0.445 fallen by 3.26%
$50 FY26 Full Year Results Announcement Details 12 Aug 2026 4:16PM $0.480 $0.445 fallen by 7.29%
$50 Appendix 4C and Quarterly Activity Report 30 June 2026 24 Jul 2026 8:24AM $0.390 $0.445 risen by 14.10%
$50 Change in substantial holding 1 Jul 2026 12:07PM $0.390 $0.445 risen by 14.10%
$50 Becoming a substantial holder 3 Jun 2026 3:23PM $0.375 $0.445 risen by 18.67%
$50 Change in substantial holding 2 Jun 2026 1:13PM $0.375 $0.445 risen by 18.67%
$50 Notification of cessation of securities - MVP 14 May 2026 1:47PM $0.435 $0.445 risen by 2.30%
$50 Appendix 4C and Quarterly Activity Report 31 March 2026 24 Apr 2026 8:58AM $0.385 $0.445 risen by 15.58%
$50 Notification of cessation of securities - MVP 20 Apr 2026 12:19PM $0.380 $0.445 risen by 17.11%
$50 Change in substantial holding 16 Apr 2026 5:03PM $0.395 $0.445 risen by 12.66%
$50 FY26 Half Year Announcement 19 Feb 2026 8:55AM $0.455 $0.445 fallen by 2.20%
$50 FY26 Half Year Presentation 19 Feb 2026 8:54AM $0.455 $0.445 fallen by 2.20%
$50 FY26 Half Year Report (including Appendix 4D) 19 Feb 2026 8:54AM $0.455 $0.445 fallen by 2.20%
$50 FY26 Half Year Announcement Details 16 Feb 2026 3:51PM $0.455 $0.445 fallen by 2.20%
$50 Appendix 4C and Quarterly Activity Report 31 December 2025 30 Jan 2026 8:22AM $0.480 $0.445 fallen by 7.29%
$50 Change of Director's Interest Notice - R Basser 3 Nov 2025 2:53PM $0.695 $0.445 fallen by 35.97%
$50 2025 Annual General Meeting Webcast recording 13 Oct 2025 11:11AM $0.710 $0.445 fallen by 37.32%
$50 Results of 2025 Annual General Meeting 10 Oct 2025 2:39PM $0.675 $0.445 fallen by 34.07%
$50 2025 Annual General Meeting Presentation 10 Oct 2025 9:05AM $0.625 $0.445 fallen by 28.80%
$50 2025 Annual General Meeting Chair and CEO addresses 10 Oct 2025 9:05AM $0.625 $0.445 fallen by 28.80%
$50 Appendix 4C and Quarterly Activity Report 30 September2025 10 Oct 2025 9:04AM $0.625 $0.445 fallen by 28.80%

1 - 25 of 620 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.